New drug nezavist takes first step toward helping heavy drinkers
NCT ID NCT06633562
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 26 times
Summary
This study tests whether a new drug called Nezavist is safe for people. Thirty-two healthy adults will receive either the drug or a placebo. Researchers will monitor side effects and how the drug moves through the body. The goal is to find a safe dose for future studies on reducing alcohol consumption in people with alcohol use disorder.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Altman Clinical and Translational Research Institute
La Jolla, California, 92037, United States
Conditions
Explore the condition pages connected to this study.